Ambulatory Blood Pressure Thresholds for Diagnosis of Hypertension in Patients With and Without Type 2 Diabetes Based on Cardiovascular Outcomes

被引:12
|
作者
Hermida, Ramon C. [1 ]
Ayala, Diana E. [1 ]
Mojon, Artemio [1 ]
Fernandez, Jose R. [1 ]
机构
[1] Univ Vigo, Bioengn & Chronobiol Labs, Vigo 36310, Pontevedra, Spain
关键词
Ambulatory blood pressure; Cardiovascular risk; Diagnostic thresholds; Type; 2; diabetes; TREATMENT-TIME REGIMEN; GENE-RELATED PEPTIDE; CIRCADIAN-RHYTHMS; PROGNOSTIC VALUE; THERAPEUTIC TARGET; MASS INDEX; RISK; CHRONOTHERAPY; PATTERN; EVENTS;
D O I
10.3109/07420528.2012.702584
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Currently recommended ambulatory blood pressure (BP) monitoring (ABPM) thresholds for diagnosis of hypertension do not differentiate, as international guidelines do for clinic BP, uncomplicated persons at low risk from those at higher risk, e. g., patients with diabetes, for target injury and cardiovascular disease (CVD) risk. We aimed to derive diagnostic thresholds for the awake and asleep systolic (SBP) and diastolic (DBP) BP means based upon CVD outcomes (death from all causes, myocardial infarction, angina pectoris, coronary revascularization, heart failure, acute arterial occlusion of the lower extremities, thrombotic occlusion of the retinal artery, hemorrhagic stroke, ischemic stroke, and transient ischemic attack) for patients with and without diabetes. We prospectively studied 3344 subjects (1718 men/1626 women), 52.6 +/- 14.5 (mean +/- SD) yrs of age, 607 with type 2 diabetes, during a median follow-up of 5.6 yrs. Those with hypertension at baseline were randomized to ingest all their prescribed hypertension medications upon awakening or the entire daily dose of >= 1 of them at bedtime. At baseline, BP was measured at 20-min intervals from 07:00 to 23:00 h and at 30-min intervals at night for 48 h, and physical activity was simultaneously monitored every minute by wrist actigraphy to accurately derive the awake and asleep BP means. Identical assessment was scheduled annually and more frequently (quarterly) if treatment adjustment was required. Cox regression analysis was used to derive outcome-based reference thresholds for ABPM in subjects with and without diabetes. CVD risk was consistently greater in patients with than without diabetes for awake SBP/DBP means >= 130/75 mm Hg and asleep means >= 110/65 mm Hg. Derived outcome-based reference thresholds for persons without diabetes were 135/85 mm Hg for the awake and 120/70 mm Hg for the asleep SBP/DBP means. In terms of CVD outcome, the equivalent cutoff threshold values for patients with diabetes were 120/75 mm Hg for the awake and 105/60 mm Hg for the asleep SBP/DBP means. Outcome-based reference thresholds for the diagnosis of hypertension were 15/10 mm Hg lower for ambulatory SBP/DBP in patients with than without diabetes. This marked difference indicates the need for revision of current guidelines that propose diagnostic thresholds for ambulatory BP without differentiation between the presence/absence of diabetes. (Author correspondence: rhermida@uvigo.es)
引用
收藏
页码:132 / 144
页数:13
相关论文
共 50 条
  • [41] Diagnosis of hypertension: Ambulatory pediatric American Heart Association/European Society of Hypertension versus blood pressure load thresholds
    Sharma, Ajay P.
    Altamirano-Diaz, Luis
    Mohamed Ali, Mohamed
    Stronks, Katryna
    Kirpalani, Amrit
    Filler, Guido
    Norozi, Kambiz
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2021, 23 (11): : 1947 - 1956
  • [42] Role of Ambulatory Blood Pressure Monitoring in Hypertension and Diabetes
    Flynn, Colleen
    Bakris, George L.
    [J]. CURRENT HYPERTENSION REPORTS, 2013, 15 (03) : 137 - 142
  • [43] Role of Ambulatory Blood Pressure Monitoring in Hypertension and Diabetes
    Colleen Flynn
    George L. Bakris
    [J]. Current Hypertension Reports, 2013, 15 : 137 - 142
  • [44] Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study
    Hata, Shinnosuke
    Ushigome, Emi
    Yoshimura, Takashi
    Takegami, Maya
    Kitagawa, Nobuko
    Tanaka, Toru
    Hasegawa, Goji
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Yokota, Isao
    Ushigome, Hidetaka
    Asano, Mai
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (12) : 2430 - 2437
  • [45] Oscillating blood pressure therapeutic target in type 2 diabetes patients with hypertension
    Tankeu, Aurel T.
    Noubiap, Jean Jacques N.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (21)
  • [46] Blood Pressure Reduction With Dapagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease
    Woo, Vincent
    Leiter, Lawrence A.
    Cefalu, William T.
    de Bruin, Tjerk W.
    Gause-Nilsson, Ingrid
    Parikh, Shamik J.
    Johnsson, Eva
    [J]. CIRCULATION, 2013, 128 (22)
  • [47] BLOOD PRESSURE AND THE RISK OF CARDIOVASCULAR DISEASE AMONG PATIENTS WITH TYPE 2 DIABETES
    Hu, G.
    [J]. CARDIOLOGY, 2014, 128 : 353 - 353
  • [48] Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase
    Sarafidis, PA
    Lasaridis, AN
    Nilsson, PM
    Pagkalos, EM
    Hitoglou-Makedou, AD
    Pliakos, CI
    Kazakos, KA
    Yovos, JG
    Zebekakis, PE
    Tziolas, IM
    Tourkantonis, AN
    [J]. JOURNAL OF HYPERTENSION, 2004, 22 (09) : 1769 - 1777
  • [49] Pediatric ambulatory blood pressure monitoring: diagnosis of hypertension
    Chaudhuri, Abanti
    [J]. PEDIATRIC NEPHROLOGY, 2013, 28 (07) : 995 - 999
  • [50] Ambulatory Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension
    Islam, Md Shahidul
    [J]. HYPERTENSION: FROM BASIC RESEARCH TO CLINICAL PRACTICE, VOL 2, 2017, 956 : 109 - 116